Differential chemokine expression under the control of peripheral blood mononuclear cells issued from Alzheimer’s patients in a human blood brain barrier model

• Julie Vérité,

  Roles Formal analysis, Investigation, Methodology, Writing – original draft

  Affiliation EA3808, molecular Targets and Therapeutics of Alzheimer’s disease, University of Poitiers, Poitiers, France

  ⨯
• Guylène Page,

  Roles Conceptualization, Formal analysis, Funding acquisition, Methodology, Project administration, Supervision, Validation, Writing – original draft

  Affiliation EA3808, molecular Targets and Therapeutics of Alzheimer’s disease, University of Poitiers, Poitiers, France

  ⨯
• Marc Paccalin,

  Roles Investigation, Writing – review & editing

  Affiliations EA3808, molecular Targets and Therapeutics of Alzheimer’s disease, University of Poitiers, Poitiers, France, Department of Geriatrics, Poitiers University Hospital, Poitiers, France, Memory Resource and Research Center of Poitiers, Poitiers University Hospital, Poitiers, France

  ⨯
• Adrien Julian ,

  Contributed equally to this work with: Adrien Julian, Thierry Janet

  Roles Investigation

  Affiliations EA3808, molecular Targets and Therapeutics of Alzheimer’s disease, University of Poitiers, Poitiers, France, Memory Resource and Research Center of Poitiers, Poitiers University Hospital, Poitiers, France, Department of Neurology, Poitiers University Hospital, Poitiers, France

  ⨯
• Thierry Janet

  Contributed equally to this work with: Adrien Julian, Thierry Janet

  Roles Formal analysis, Methodology, Project administration, Supervision, Validation, Writing – original draft

  * E-mail: thierry.janet@univ-poitiers.fr

  Affiliation EA3808, molecular Targets and Therapeutics of Alzheimer’s disease, University of Poitiers, Poitiers, France

  http://orcid.org/0000-0002-8742-3748

  ⨯